Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CLS obtains first order for its diffusor fiber, for MRI-guided laser ablation, from a leading cancer clinic in the US

Clinical Laserthermia Systems (CLS) (publ), has received its first order for the company’s product TRANBERG®|Laser Applicator Non-cooled diffusor fiber for MRI-guided laser ablation. The purchase order comes from the same leading US hospital that earlier this year bought the TRANBERG® |Mobile Laser Unit. The background to the purchase is the hospital’s extensive operations in the area of image-guided minimal invasive treatment of tumors. Together the parties are preparing for a collaboration in order to evaluate, and further develop, CLS proprietary immunostimulating treatment, imILT®,

Safe at Sea enters the German SAR market

We are very proud to announce that DLRG (Deutsche Lebens-Rettungs-Gesellschaft e.V), the German Life Saving Organization has chosen to invest in a RescueRunner system for their Search and Rescue operations across Germany.DLRG has during the winter / spring 2017 sent two delegations to test the RescueRunner system in Sweden and it has been a very valuable cooperation between them, SSRS (Swedish Sea Rescue Society) and Safe at Sea, learning and understanding their requirements, operations and needs to be able to provide them with a suitable solution. The RescueRunner system will be the

ADDvise wins public tender worth 7 MSEK

ADDvise Group AB’s (publ) subsidiary Hettich Labinstrument has received an allocation decision from Stockholms Läns Landsting regarding a delivery of blood collection products. The products are primarily vacuum tubes and safety products and the delivery start is in October 2017. The contract will run for two years with the possibility of a one year extension for up to two years. The order is worth approximately 7 MSEK the first two years and the agreement has a standstill period until June 14th 2017, then Hettich has the right to sign the agreement with SLL. For further information,

Cinnober launches risk management system tailored uniquely to CCP needs

Risk and collateral management – fit for the new clearing landscape with growing volumes and versatile scope of cleared contractsCinnober  announces the launch of a stand-alone risk management solution dedicated to the needs of central clearing counterparties (CCPs). The post-financial crisis regulations, including Basel III, EMIR and Dodd Frank, have transformed the landscape for clearinghouses. A wider range of contracts are traded on electronic platforms and cleared centrally, and the importance of CCPs as safeguards of financial stability has increased. “

Valmet celebrates 1,000 customer pilot trials at its Tissue Technology Center in Karlstad, Sweden

Valmet Oyj's trade press release on June 5, 2017 at 11:00 a.m. On Thursday May 4 Valmet Tissue Technology Center celebrated its thousandth external customer pilot trial in Karlstad, Sweden.  The very special occasion was celebrated together with the Tissue research cluster managed by RISE, who are conducting development work together with the Valmet R&D team. The thousandth customer tissue trial were celebrated by the whole Valmet and RISE team Valmet's Tissue Technology Center has a long history of being a base for Valmet's tissue technology research and development, as

Detection Technology Plc - Managers' Transactions

Detection Technology Plc Managers' Transactions 5 June 2017 at 10:30 (EEST) Detection Technology Plc - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Hyvärinen, Kari Position: Other senior manager Issuer: Detection Technology Plc LEI: 743700IXKYKNXJ6BFL39 Notification type: INITIAL NOTIFICATION Reference number: 743700IXKYKNXJ6BFL39_20170605085705_2 ____________________________________________ Transaction date: 2017-06-02 Venue: FIRST NORTH FINLAND (FNFI) Instrument type: SHARE

Ahlstrom-Munksjö announces indicative Tender Offer results

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE OFFERING OF THE NEW NOTES (AS DEFINED BELOW), THE TENDER OFFER (AS DEFINED BELOW) OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. AHLSTROM-MUNKSJÖ STOCK EXCHANGE RELEASE, JUNE 5, 2017 at 8:50 CEST Ahlstrom-Munksjö Oyj (the “Company”) announces today the indicative results of the invitation to the holders of

OV- The efficacy of chemotherapy with epirubicin, one the of most used drugs in Breast Cancer can now be predicted by DRP – Poster published at ASCO

Hoersholm, Denmark, June 5th, 2017 – Oncology Venture Sweden AB (“Oncology Venture”) today announced that the previously published abstract with DRP data for epirubicin for breast cancer was presented as a poster on the poster session ‘Breast Cancer—Metastatic’ Board 63; Abstract 1071 on the 4th of June 2017 at 8:00 AM-11:30 AM local time/15:00-18:30 CET. The title is “Retrospective-prospective blinded evaluation predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort”.  The DRP was significantly associated

Sea Shepherd Germany announces Baltic Sea Campaign with new patrol ship

With a new patrol ship donated by Dr. Bronner’s, Sea Shepherd’s new campaign aims to protect critically endangered harbor porpoises in the Baltic Sea.FOR IMMEDIATE RELEASE June 5, 2017 The Baltic Sea harbor porpoise is listed by the IUCN (International Union for Conservation of Nature) as “critically endangered”, with a population estimated to be less than 500 individuals in 2016. The harbor porpoise is protected under EU law, and therefore member states are obliged to take measures to ensure the protection of their natural habitats. However, because of exemptions to these

Episurf Medical AB will be exhibiting at the Irish Orthopaedic Association's Annual Meeting, held in Kilkenny, Ireland, on June 16-18

Episurf Medical AB will participate at Irish Orthopaedic Association's Annual Meeting, an orthopaedic conference held in Kilkenny, Ireland, (Lyrath Hotel) on June 16-18. For full program, see link. . For an overview of the industry conferences attended by Episurf Medical, see link. (www.episurf.com/healthcare-professionals/conferences).  For more information, please contact: Pål Ryfors, CEO, Episurf Medical  Tel: +46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint

Chinmax Medical Systems Inc. to distribute Acetium® Lozenge in China

Biohit Oyj press release 5 June 2017 at 9:30 am. local time (EEST) Biohit Oyj and Chinmax Medical Systems Inc. have signed an agreement for the distribution of the Acetium lozenge in China. The agreement has been signed for a preliminary period of seven years and includes an option and a letter of intent for a joint venture arrangement and local production if the sales targets set out in the agreement are met. The Acetium lozenge can be used to bind carcinogenic acetaldehyde in saliva to a harmless compound during smoking and to promote oral health. Acetium lozenge has been found to

Diamyd Medical subscribes for an additional SEK 1 million in NextCell Pharma’s ongoing new issue ahead of IPO

Diamyd Medical announces today that the Company will subscribe for an additional SEK 1 million in the ongoing new issue in the associated company NextCell Pharma AB (NCP) ahead of their planned IPO in July on Aktietorget."A listing of NextCell Pharma is clearly positive for Diamyd Medical as it provides a transparent value of our holdings and better risk diversification, while giving NCP greater opportunities to drive its research and business development," says Ulf Hannelius, CEO of Diamyd Medical. NextCell Pharma develops advanced cell therapies with own and donated stem cells. The

Notice of the Extraordinary General Meeting 2017

The shareholders of Avanza Bank Holding AB (publ.) are hereby given notice of the Extraordinary General Meeting of the company to be held on Wednesday, 5 July 2017 at 10.00 (CET) at Konferens Spårvagnshallarna, Birger Jarlsgatan 57 A, in Stockholm.Entitlement to attend the General Meeting Shareholders wishing to attend the General Meeting shall, firstly, be entered in the register of shareholders maintained by Euroclear Sweden AB no later than Thursday, 29 June 2017, and secondly, notify of their intention to participate in the General Meeting by email to bolag@avanza.se or by telephone

Directorate Changes

5 June 2017 Genel Energy plc Directorate Changes Genel Energy plc (‘Genel’ or ‘the Company’) announces that Nathaniel Rothschild and Simon Lockett have resigned from the Board. Accordingly, they will no longer stand for re-election at the Annual General Meeting of Genel Energy on 6 June 2017. Simon Lockett was Chairman of the HSSE Committee and member of the Audit and Nomination Committees. Board Committee memberships are under review and updates will be made when appropriate. Tony Hayward, Chairman of Genel, said: "Nat contributed greatly to Genel’s development as both a

Information about insider transaction at SaltX Technology

The Executive Vice President and CTO of SaltX Technology, Göran Bolin has per June 2, 2017, sold 159 000 B-shares (including BTA) and 135 064 warrants TO2 of his holding in SaltX Technology Holding AB. The sale, which has been registered at Finansinspektionen, was done due to personal financial reasons. After the sale, Göran Bolin holds a total of 133 200 B-shares (including BTA) in the Company, as well as 166 000 warrants TO2 and 100 000 TO3.For further information, please contact: Harald Bauer, CFO SaltX Technology, phone +46 (0)708 10 80 34

Finnair’s Pekka Vauramo to be oneworld Governing Board Chairman

Pekka Vauramo, Chief Executive of Finnair, has been nominated by the Governing Board of the oneworld® global airline alliance to serve as its Chairman for the two years ahead. He took up the role at oneworld’s mid-year Board meeting, held today in Cancun, where airline industry leaders from around the world are gathering for the IATA annual meeting which opens tomorrow. He succeeds Ivan Chu, who has moved on from his role as Chief Executive of Cathay Pacific Airways to become Chairman of John Swire & Sons (China) Limited, after leading the alliance for two years. His successor as

Nordic Waterproofing provides an update of the competition case

On 31 May 2017, as communicated by Nordic Waterproofing by an announcement on the same day, the Danish Competition and Consumer Authority (the “DCCA”) issued a decision (“the Decision”) to providers of waterproofing products in Denmark, including Nordic Waterproofing A/S, a Danish subsidiary of Nordic Waterproofing Holding A/S (STO:NWG.ST). The Decision relates to the application of the standard setting organization TOR’s product standards for waterproofing products and orders TOR to repeal its product standards and Nordic Waterproofing to seize its participation in TOR.Also as previously

WINDPASSENGER: FLY WITHOUT WINGS MARKET LEADERS IN PORTUGAL SINCE 2004

PORTUGAL: AN INCREASINGLY MORE ATTRACTIVE DESTINATIONPortugal has been establishing itself as a major international tourist destination.   Every year it succeeds as the best tourist destination, with the best beaches, best short-breaks...   From Lisbon to Oporto, from Alentejo to Algarve to the amazing North and country's interior, Portugal has a rich historical, cultural and natural heritage capable of satisfying the most demanding tastes.   But if you already know all of Portugal charms, seen from the ground, discover the country from another perspective.  Climb aboard a hot air

Pirjo Pakkanen is resigning the Board of Directors of Tecnotree Corporation

Tecnotree CorporationStock Exchange Release3 June 2017 at 13:30 pm EET   Pirjo Pakkanen is resigning the Board of Directors of Tecnotree CorporationPirjo Pakkanen, the Board Member of Tecnotree Corporation is resigning the Board of Directors of the company. The resignation is effective immediately. Thereafter, the Board has four members.TECNOTREE CORPORATIONThe Board of DirectorsMORE INFORMATIONHarri Koponen, Chairman of the Board, tel. +358 40 1922 464 About TecnotreeTecnotree is a global provider of IT solutions for the management of services, products, customers

Nevada Becomes 23rd State to Modernize Insurance Laws Allowing E-Card, E-Delivery and E-Posting

CARSON CITY, Nev. — With the recent signature of AB 455 by Gov. Brian Sandoval, Nevada becomes the 23rd state to modernize insurance laws to keep pace with how consumers want to receive their insurance policy documents and information, says the Property Casualty Insurers Association of America (PCI).  Assembly Bill 455 gives consumers the choice to receive their insurance policies, documents and consumer notices electronically. This legislation also enables insurers to post standard policy forms and endorsements online in lieu of mailing paper documents. “Increasingly consumers want to

NRC Group ASA - Acquisitions of own shares

Oslo, 2 June 2017. Reference is made to the announcement made by NRC Group ASA (the "Company"') on 11 May 2017 in connection with its decision to initiate a share buyback program for up to NOK 10 million in the market. The Company has today bought 50.000 shares in the Company through broker at an average price of NOK 56.2263 per share.The Company's total holding of treasury shares after this transaction is 268.165 shares.For further information, please contact:CFO Dag Fladby, telephone: +47 90 89 19 35.This information is subject to the disclosure requirements pursuant to section

Kamux Oyj: Stabilization measures taken

Kamux Corporation   Stock Exchange Release   2 June 2017 at 20:00 Not for publication, distribution or release, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, Singapore, or any other jurisdiction where it would be against the law. Stabilization measures taken With reference to the offering circular published by Kamux Corporation ("Kamux", "Company") on 2 May 2017 and company announcement dated on 11 May 2017 regarding the result of the initial public offering of Kamux (the "Offering"), Kamux

Regarding proposals to Vigmed's annual general meeting 2017

The nomination committee of Vigmed Holding AB has notified the company that, in view of Vigmed's new ownership structure, the nomination committee will not submit any proposals to the annual general meeting 2017.  Vigmed's new majority shareholder, Greiner Bio-One GmbH ("GBO"), has notified Vigmed that GBO will submit proposals to the annual general meeting 2017 as soon as possible. Vigmed will announce the proposals as soon as they have been received by the company.For further information contact:Chairman of the Board Sten Dahlborg, +46 708-369 419This is a translation of the

BioStock publishes analysis of Idogen

Today, June 2 2017, BioStock has published an analysis of Idogen. The analysis is now available on BioStock’s, Idogen’s and Redeye’s respective websites (www.biostock.se ,  www.idogen.com , http://beta.redeye.se/transaction/idogen). On behalf of Idogen, Biostock has analyzed the company’s project portfolio and will continue to follow the company for one year.Extract from BioStock’s analysis: “BioStock has analyzed deal values

There are no items matching the current filter
There are no more items matching the current filter
Back to top